oral polio vaccine + information — Competitive Intelligence Brief

oral polio vaccine + information (oral polio vaccine + information) competitive landscape: 6 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Live attenuated vaccine. Area: Immunology / Infectious Disease.

marketed Live attenuated vaccine Poliovirus types 1, 2, and 3 Immunology / Infectious Disease Biologic

Target snapshot

oral polio vaccine + information (oral polio vaccine + information) — Bandim Health Project. Oral polio vaccine stimulates the immune system to produce antibodies against poliovirus types 1, 2, and 3, providing protection against poliomyelitis infection.

Comparator set (6 drugs)

Drug	Generic	Sponsor	Phase	Class	Target	Approval / PDUFA
oral polio vaccine + information TARGET	oral polio vaccine + information	Bandim Health Project	marketed	Live attenuated vaccine	Poliovirus types 1, 2, and 3
DTacP-IPV combined vaccine (TETRAXIM™)	DTacP-IPV combined vaccine (TETRAXIM™)	Sanofi	marketed	Combination inactivated vaccine	Diphtheria toxin, tetanus toxin, Bordetella pertussis antigens (PT, FHA, PRN), poliovirus types 1, 2, and 3
2wIPV+1sIPV	2wIPV+1sIPV	Sinovac Biotech Co., Ltd	marketed	Inactivated viral vaccine	Poliovirus types 1, 2, and 3 antigens
sIPV batch 3	sIPV batch 3	Institute of Medical Biology, Chinese Academy of Medical Sciences	marketed	Inactivated viral vaccine	Poliovirus types 1, 2, and 3
IPV at 6 weeks of age	IPV at 6 weeks of age	Centers for Disease Control and Prevention	marketed	Inactivated viral vaccine	Poliovirus types 1, 2, and 3
sIPV batch 1	sIPV batch 1	Institute of Medical Biology, Chinese Academy of Medical Sciences	marketed	Inactivated viral vaccine	Poliovirus types 1, 2, and 3
fIPV (0.1 mL) ID	fIPV (0.1 mL) ID	Centers for Disease Control and Prevention	marketed	vaccine	poliovirus types 1, 2, and 3 antigens

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Live attenuated vaccine class)

1. GlaxoSmithKline · 19 drugs in this class
2. Merck Sharp & Dohme LLC · 11 drugs in this class
3. Sanofi Pasteur, a Sanofi Company · 9 drugs in this class
4. PATH · 5 drugs in this class
5. Sanofi · 5 drugs in this class
6. Bandim Health Project · 5 drugs in this class
7. Centers for Disease Control and Prevention · 3 drugs in this class
8. International Centre for Diarrhoeal Disease Research, Bangladesh · 3 drugs in this class
9. Beijing Center for Disease Control and Prevention · 2 drugs in this class
10. Aga Khan University · 2 drugs in this class